Patent ID: 11873295
Assignee: PETRA PHARMA CORPORATION
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 15:
16. The compound of claim 1, or pharmaceutically acceptable salt thereof, wherein each R10 is independently —H, —CN, halogen, C1-C6 haloalkyl, C1-C6 alkoxy, —SO2R11, —CONR11R11, an optionally substituted C1-C6 alkyl, an optionally substituted C3-C5 cycloalkyl, an optionally substituted heterocycle selected from pyrrolidine, pyrrolidinone, piperidine or morpholine, or an optionally substituted heteroaryl selected from selected from pyrazole, isoxazole, isothiazole, imidazole, oxazole, or thiazole; wherein the optionally substituted C1-C6 alkyl is optionally substituted with a —CN, —OH, or C1-C3 alkoxy; and the optionally substituted C3-C5 cycloalkyl, heterocycle or heteroaryl is each optionally substituted with one to three substituents each independently selected from halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, —NR11R11, —OH or —CN.